Incyte – EHA 2026 Hematology Data

Summary Incyte announced more than 20 hematology and oncology presentations for EHA 2026, highlighted by plenary Phase 3 frontMIND data in frontline diffuse large B-cell lymphoma (DLBCL) and new clinical data for INCA033989, a mutation-specific antibody targeting mutant calreticulin in myeloproliferative neoplasms (MPNs). What Happened…